Diagnostic and Interventional Cardiology

Results also demonstrate the benefits for patients of Abbott's TriClip™ for tricuspid regurgitation, Amulet™ for atrial fibrillation and Portico™ for aortic stenosis

News | Structural Heart

Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies

September 17, 2022 — Abbott today announced data from five late-breaking presentations showing the benefits of its ...

September 17, 2022

Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets

News | Structural Heart

First-ever Comparison of MicroCT and Histology in Self-expanding Transcatheter Aortic Valve Replacement Patients with Hypo-attenuated Leaflet Thickening

September 17, 2022 — Medtronic today announced findings from its Pathological Study of Hypo-Attenuated Leaflet ...

September 17, 2022

The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)

News | Hemodynamic Support Devices

Unloading with Impella for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients

September 17, 2022 — Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To ...

September 17, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Results from largest randomized TAVR trial to date presented at TCT 2022

News | Embolic Protection Devices

Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL Cerebral Protection System

September 17, 2022 — Boston Scientific Corporation has announced results from the PROTECTED TAVR clinical trial ...

September 17, 2022

Edwards Lifesciences Corporation, today announced the company's PASCAL Precision transcatheter valve repair system for transcatheter edge-to-edge repair (TEER) has received FDA approval for the treatment of patients with degenerative mitral regurgitation (DMR).

News | TCT

Edwards Pascal Precision Transcatheter Valve Repair System Receives FDA Approval for Degenerative Mitral Regurgitation

September 16, 2022 — Edwards Lifesciences Corporation, today announced the company's PASCAL Precision transcatheter ...

September 16, 2022

Results from Largest Ever Real-World Evaluation of the MANTA Device Demonstrated Safety and Effectiveness with Low Complication Rates and a Short Learning Curve

News | Vascular Closure Devices

Co-Author of the Karolinska 1000 Consecutive MANTA Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference

September 16, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced that Dr. Magnus ...

September 16, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

The CathWorks FFRangio System to Be Featured in Multiple Live Cases and Clinical Presentations at TCT 2022

News | TCT

CathWorks Announces Key Events for TCT 2022

September 16, 2022 — CathWorks announced today the schedule of key events for the company during Cardiovascular Research ...

September 16, 2022

RECOVER IV is an on-label, two arm RCT that is designed to provide the clinical evidence needed to achieve a Class I guideline recommendation for Impella use in AMI cardiogenic shock.

News | Cardiogenic Shock

FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC)

September 16, 2022 — Abiomed announced two approvals from the U.S. Food and Drug Administration (FDA) related to ...

September 16, 2022

Study suggests prescribing Philips MCOT (Mobile Cardiac Outpatient Telemetry) solution may support improved patient outcomes and cost savings by monitoring for arrhythmic disturbances and encouraging timely intervention

News | Heart Failure

New Study Validates Ambulatory Monitoring as a Critical Component of Cardiac Care

September 15, 2022 — Today, aortic stenosis (AS) is one of the most common and serious valve disease problems [1]. It ...

September 15, 2022

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Dr. Valentin Fuster to be honored with the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Career Achievement Award. Image courtesy of Mount Sinai Health System

News | TCT

Valentin Fuster, M.D., Ph.D., Receives Prestigious Award from Cardiovascular Research Foundation

September 15, 2022 — The Cardiovascular Research Foundation (CRF) will honor Valentin Fuster, MD, PhD, Director of Mount ...

September 15, 2022

Global consensus data recommends the use of intravascular ultrasound (IVUS) in many peripheral vascular disease (PVD) procedures

News | TCT

Philips Showcases Clinical Data and Solutions Designed to Deliver Better Cardiac Care with Greater Efficiency at TCT 2022

September 15, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its ...

September 15, 2022

Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital health company designed the app to support researchers and advance the adoption of digital health technology in cardiac practice.

News | Cardiac Diagnostics

European digital health company launches app to support cardiac health

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

September 15, 2022

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Cardiac Implants LLC has announced the successful initial deployment of its Annuloplasty ring with implementation of a therapeutic adjustment procedure using its innovative Tri-Ring percutaneous annuloplasty device.

News | Heart Valve Technology

Cardiac Implants Announces Successful Therapeutic Adjustment Procedure Using Tri-Ring Percutaneous Annuloplasty Device

September 15, 2022 — Cardiac Implants LLC has announced the successful initial deployment of its Annuloplasty ring with ...

September 15, 2022

Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INterventional Strategies) and VIVA (Vascular InterVentional Advances) Annual Conference, Oct. 30-Nov. 3, 2022, have been announced.

News | Cardiovascular Education

Late-breaking Clinical Trial presentations announced for The VEINS and VIVA Conference

September 14, 2022 — Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular ...

September 14, 2022

A budget impact analysis published in the Canadian Journal of Cardiology compared the use of surgical (SAVR) versus catheter-based transcatheter aortic valve replacement (TAVR)

News | Heart Failure

TAVR is an Affordable and Effective Strategy for Treating Aortic Stenosis Patients

September 14, 2022 — Minimally invasive, catheter-based transcatheter aortic valve replacement (TAVR) has revolutionized ...

September 14, 2022